CS-0777

CAS No. 827344-05-8

CS-0777( CS 0777 | CS0777 )

Catalog No. M16073 CAS No. 827344-05-8

A potent, selective, orally active S1P receptor-1 (S1P1) agonist with EC50 of 1.1 nM, 320-fold selectivity over S1P3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CS-0777
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally active S1P receptor-1 (S1P1) agonist with EC50 of 1.1 nM, 320-fold selectivity over S1P3.
  • Description
    A potent, selective, orally active S1P receptor-1 (S1P1) agonist with EC50 of 1.1 nM, 320-fold selectivity over S1P3; significantly decreases lymphocyte counts at doses of 0.1 and 1 mg/kg in rats, demonstrates potential benefits in the treatment of autoimmune diseases.Multiple Sclerosis Phase 3 Clinical
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CS 0777 | CS0777
  • Pathway
    GPCR/G Protein
  • Target
    Lysophospholipid Receptor
  • Recptor
    Lysophospholipid Receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    Multiple Sclerosis

Chemical Information

  • CAS Number
    827344-05-8
  • Formula Weight
    342.483
  • Molecular Formula
    C21H30N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=CC=C(C=C1)CCCC(=O)C2=CC=C(N2C)CCC(C)(CO)N
  • Chemical Name
    (R)-1-(5-(3-amino-4-hydroxy-3-methylbutyl)-1-methyl-1H-pyrrol-2-yl)-4-(p-tolyl)butan-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nishi T, et al. ACS Med Chem Lett. 2011 Mar 2;2(5):368-72. 2. Yonesu K, et al. J Biol Chem. 2011 Jul 15;286(28):24765-75. 3. Moberly JB, et al. J Neuroimmunol. 2012 May 15;246(1-2):100-7. 4. Inaba S, et al. Xenobiotica. 2015;45(12):1063-80.
molnova catalog
related products
  • Amiselimod hydrochlo...

    A novel prodrug S1P receptor modulator lacking S1P3 receptor agonism to avoid bradycardia associated with fingolimod and other S1P receptor modulators.

  • Mocravimod

    A synthetic immunosuppressant that functions as a S1P1 receptor agonist.

  • Etrasimod

    Etrasimod (APD334) is a potent, selective, centrally available S1P1 receptor antagonist with β-arrestin EC50 of 6.1 nM, internalizes human S1P1 in CHO cells expressing HA tagged S1P1 with IC50 of 1.88 nM.